Source: GlobalNewswire

Press Release: LayerBio : LayerBio Granted U.S. Patent for OcuRing Drug Delivery Platform

Novel sustained-release technology has potential to eliminate the need for eye drops after cataract surgery.Novel sustained-release technology has potential to eliminate the need for eye drops after cataract surgery.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Kenneth J. Mandell's photo - President & CEO of LayerBio

President & CEO

Kenneth J. Mandell

CEO Approval Rating

87/100

Read more